Differential responses of intracisternal injection of interleukin-1 β to acute and inflammatory orofacial pain model in freely moving rats

Neuroscience Research Communications

Volumn 31, Issue 3, 2002, Pages 145-154

  Choi, Hyo S ^a   Park, Jae S ^b   Ahn, Dong K ^a,c  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Cytokines; Formalin test; Freely moving rat; IL 1 ; JOR

Indexed keywords

FORMALDEHYDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ELECTROMYOGRAM; FACE; HYPERALGESIA; INJECTION; JAW OPENING REFLEX; MALE; MOUTH; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PHARMACOLOGICAL BLOCKING; RAT;

EID: 0036872794     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/nrc.10047     Document Type: Article

References (27)

1. Adams JU, Bissiere JL, Geller EB, Adler MW. Interleukin-1 did not induce analgesia in the rat hot-plate or old water tail-flick tests. Soc Neurosci Abstract 1992; 18: 1012.
2. Ahn DK, Kim KH, Ju JS, Kwon SK, Park JS. Microinjection of arginine vasopressin into the central nucleus of amygdala suppressed nociceptive jaw opening reflex in freely moving rats. Brain Res Bull 2001; 55(1): 117-121.
3. Ahn DK, Kim YS, Park JS. Central amygdaloid carbachol suppressed nociceptive jaw opening reflex in freely moving rats. Prog Neuro-Psychopharmacol & Biol Psychiat 1999; 23: 685-695.
4. Ahn DK, Kim YS, Park JS. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 1998; 243(1-3): 105-108.
5. Bianchi M, Sacerdote P, Locatelli L, Mantegazza P, Panerai AE. Corticotropin releasing hormone, interleukin-1α, and tumor necrosis factor-α share characteristics of stress mediators. Brain Res 1991; 546: 139-142.
6. Bianchi M, Sacerdote P, Ricciardi-Castagnoli P, Man-tegazza P, Panerai AE. Central effects of tumor necrosis factor α and interleukin-1α on nociceptive thresholds and spontaneous locomotor activity. Neurosci Lett 1992; 148: 76-80.
7. Clavelou P, Pajot J, Dallel R, Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett 1989; 103: 349-353.
8. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000; 130: 1418-1424.
9. Czlonkowski A, Stein C, Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 1993; 242: 229-235.
10. Dinarello CA. Biology of interleukin 1. FASEB 1998; J 2: 108-115.
11. Falchi M, Ferrara F, Gharib C, Dib B. Hyperalgesic effect of intrathecally administered interlekin-1 in rats. Drug Exp Clin Res 2001; 27: 97-101.
12. Farrar WL, Kilian PL, Ruff MR, Hill JM, Pert CB. Visualization and characterization of interleukin 1 receptors in brain. J Immunol 1987; 139: 459-463.
13. Gilbert SD, Clark TM, Flores CM. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 2001; 89: 159-165.
14. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985; 228: 497-499.
15. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC) II: Lack of effect on non-convergent neurons, supraspinal involvement and theoretical implications. Pain 1979; 6: 305-327.
16. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M. Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci Lett 1991; 123: 254-156.
17. Morton CR, Maisch B, Zimmermann M. Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat. Brain Res 1987; 410: 347-352.
18. Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. II. Noxious visceral stimuli inhibit cutaneous nociceptive neurons and reflexes. J Neurophysiol 1991; 66: 29-39.
19. Oka T, Aou S, Hori T. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats. Brain Res 1993; 624: 61-68.
20. Oka T, Aou S, Hori T. Intracerebroventricular injection of interleukin-1β enhances nociceptive neuronal responses of the trigeminal nucleus caudatis in rats. Brain Res 1994; 656: 236-244.
21. Reeve AJ, Patel S, Fox A, Walker K, Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eup J Pain 2000; 4: 247-257.
22. Schafer M, Carter L, Stein C. Interleukin 1 β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91: 4219-4223.
23. Souter AJ, Garry MG. Spinal interleukin-1β reduces inflammatory pain. Pain 2000; 86: 63-68
24. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for tha involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997; 71: 225-235.
25. Watkins LR, Wiertelak, EP, Goehler, LE, Smith KP, Martin D, Maier SF. Characterization of cytokine induced hyperalgesia. Brain Res 1994; 564: 15-26
26. Yabuuchi K, Nishiyori A, Minami M, Satoh M. Biphasic effects of intracerebroventricular interleukin-1β on mechanical nociception in the rat. Eup J Pharmacol 1996; 300: 59-65.
27. Yaksh TL, Rudy TA. Chronic catherization of spinal subarachnoid space. Physiol Behav 1976; 17: 1031-1036.